Literature DB >> 2454751

Three types of vitronectin in human blood.

K Kubota1, S Katayama, M Matsuda, M Hayashi.   

Abstract

Vitronectin is a cell-adhesive glycoprotein in serum and plasma, also termed serum spreading factor and complement S-protein. It consists of a mixture of a polypeptide of molecular weight 75 kilodalton (kDa) and its nicked product of 65 kDa plus 10 kDa. By a quantitative immunoblotting assay, human blood samples could be classified into three distinct vitronectin types; type I (58% of the population) was 75 kDa rich and 65 kDa poor, type II (35% of the population) contained approximately equal amounts of 75 kDa and 65 kDa, and type III (5% of the population) was 75 kDa poor and 65 kDa rich. The vitronectin type did not correlate with age, sex, or ABO blood type.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2454751     DOI: 10.1247/csf.13.123

Source DB:  PubMed          Journal:  Cell Struct Funct        ISSN: 0386-7196            Impact factor:   2.212


  4 in total

1.  Vitronectin: a promising breast cancer serum biomarker for early diagnosis of breast cancer in patients.

Authors:  Wende Hao; Xuhui Zhang; Bingshui Xiu; Xiqin Yang; Shuofeng Hu; Zhiqiang Liu; Cuimi Duan; Shujuan Jin; Xiaomin Ying; Yanfeng Zhao; Xiaowei Han; Xiaopeng Hao; Yawen Fan; Heather Johnson; Di Meng; Jenny L Persson; Heqiu Zhang; XiaoYan Feng; Yan Huang
Journal:  Tumour Biol       Date:  2016-01-11

Review 2.  The role of vitronectin as multifunctional regulator in the hemostatic and immune systems.

Authors:  K T Preissner
Journal:  Blut       Date:  1989-11

3.  Calcium and hydroxyapatite binding site of human vitronectin provides insights to abnormal deposit formation.

Authors:  Kyungsoo Shin; James E Kent; Chandan Singh; Lynn M Fujimoto; Jinghua Yu; Ye Tian; Wonpil Im; Francesca M Marassi
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-22       Impact factor: 11.205

4.  Structure of human Vitronectin C-terminal domain and interaction with Yersinia pestis outer membrane protein Ail.

Authors:  Kyungsoo Shin; Bernhard C Lechtenberg; Lynn M Fujimoto; Yong Yao; Sara Schesser Bartra; Gregory V Plano; Francesca M Marassi
Journal:  Sci Adv       Date:  2019-09-11       Impact factor: 14.136

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.